These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 16484355
21. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J. Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093 [Abstract] [Full Text] [Related]
22. Hepatic Steatosis: Assessment with Acoustic Structure Quantification of US Imaging. Son JY, Lee JY, Yi NJ, Lee KW, Suh KS, Kim KG, Lee JM, Han JK, Choi BI. Radiology; 2016 Jan; 278(1):257-64. PubMed ID: 26121121 [Abstract] [Full Text] [Related]
23. Material density hepatic steatosis quantification on intravenous contrast-enhanced rapid kilovolt (peak)-switching single-source dual-energy computed tomography. Patel BN, Kumbla RA, Berland LL, Fineberg NS, Morgan DE. J Comput Assist Tomogr; 2013 Jan; 37(6):904-10. PubMed ID: 24270112 [Abstract] [Full Text] [Related]
25. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Kim DY, Park SH, Lee SS, Kim HJ, Kim SY, Kim MY, Lee Y, Kim TK, Khalili K, Bae MH, Lee JY, Lee SG, Yu ES. Eur Radiol; 2010 Feb; 20(2):359-66. PubMed ID: 19727755 [Abstract] [Full Text] [Related]
26. Unenhanced computed tomography for non-invasive diagnosis of hepatic steatosis with low tube potential protocol. Choi Y, Kim DK, Youn SY, Kim H, Choi JI. Quant Imaging Med Surg; 2022 Feb; 12(2):1348-1358. PubMed ID: 35111629 [Abstract] [Full Text] [Related]
27. Preoperative Evaluation of Liver Parenchyma of Potential Donors in Living Donor Liver Transplantation. Novruzov N, Bayramov N, Mammadov E. Transplant Proc; 2019 Sep; 51(7):2379-2382. PubMed ID: 31474295 [Abstract] [Full Text] [Related]
28. CT-based visual grading system for assessment of hepatic steatosis: diagnostic performance and interobserver agreement. Park HJ, Kim KW, Kwon HJ, Lee S, Kim DW, Moon HH, Song GW, Lee SG. Hepatol Int; 2022 Oct; 16(5):1075-1084. PubMed ID: 35789473 [Abstract] [Full Text] [Related]
29. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES. Eur Radiol; 2012 May; 22(5):1075-82. PubMed ID: 22138733 [Abstract] [Full Text] [Related]
30. Quantification of liver fat content with ultrasonographic attenuation measurement function: Correlation with unenhanced multidimensional computerized tomography. Cerit M, Şendur HN, Cindil E, Erbaş G, Yalçın MM, Cerit ET, Allahverdiyeva S, Oktar SÖ, Yücel C. Clin Imaging; 2020 Sep; 65():85-93. PubMed ID: 32387801 [Abstract] [Full Text] [Related]
31. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy? Yoon JH, Lee JM, Suh KS, Lee KW, Yi NJ, Lee KB, Han JK, Choi BI. Radiology; 2015 Aug; 276(2):453-64. PubMed ID: 25763828 [Abstract] [Full Text] [Related]
32. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Hwang S, Lee SG, Jang SJ, Cho SH, Kim KH, Ahn CS, Moon DB, Ha TY. Liver Transpl; 2004 Jun; 10(6):721-5. PubMed ID: 15162464 [Abstract] [Full Text] [Related]
33. Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing. Lawrence DA, Oliva IB, Israel GM. AJR Am J Roentgenol; 2012 Jul; 199(1):44-7. PubMed ID: 22733892 [Abstract] [Full Text] [Related]
34. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters. Yoo J, Joo I, Jeon SK, Park J, Yoon SH. Eur Radiol; 2024 Sep; 34(9):6205-6213. PubMed ID: 38393403 [Abstract] [Full Text] [Related]
35. Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU. Liver Transpl; 2006 Sep; 12(9):1403-11. PubMed ID: 16724340 [Abstract] [Full Text] [Related]
36. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H. Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669 [Abstract] [Full Text] [Related]
37. Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard. Pickhardt PJ, Blake GM, Graffy PM, Sandfort V, Elton DC, Perez AA, Summers RM. AJR Am J Roentgenol; 2021 Aug; 217(2):359-367. PubMed ID: 32936018 [Abstract] [Full Text] [Related]
38. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant. Hong YM, Yoon KT, Cho M, Chu CW, Rhu JH, Yang KH, Lee JW. Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854 [Abstract] [Full Text] [Related]
39. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, Horii SC. AJR Am J Roentgenol; 1998 Sep; 171(3):659-64. PubMed ID: 9725292 [Abstract] [Full Text] [Related]
40. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. Park BJ, Kim YJ, Kim DH, Kim W, Jung YJ, Yoon JH, Kim CY, Cho YM, Kim SH, Lee KB, Jang JJ, Lee HS. J Gastroenterol Hepatol; 2008 Jun; 23(6):900-7. PubMed ID: 17995942 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]